CL2020003368A1 - Composicion y metodo para tratar el dolor - Google Patents

Composicion y metodo para tratar el dolor

Info

Publication number
CL2020003368A1
CL2020003368A1 CL2020003368A CL2020003368A CL2020003368A1 CL 2020003368 A1 CL2020003368 A1 CL 2020003368A1 CL 2020003368 A CL2020003368 A CL 2020003368A CL 2020003368 A CL2020003368 A CL 2020003368A CL 2020003368 A1 CL2020003368 A1 CL 2020003368A1
Authority
CL
Chile
Prior art keywords
composition
treating pain
pain
cannabidiol
tetrahydrocannabinol
Prior art date
Application number
CL2020003368A
Other languages
English (en)
Inventor
Harry Karelis
Original Assignee
Zelira Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zelira Therapeutics Operations Pty Ltd filed Critical Zelira Therapeutics Operations Pty Ltd
Publication of CL2020003368A1 publication Critical patent/CL2020003368A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La invención se refiere a composiciones farmacéuticas que comprenden ?9- tetrahidrocannabinol (THC), cannabidiol (CBD) y una fracción de terpeno obtenida por extracción de una planta de Cannabis, y su uso en el tratamiento del dolor.
CL2020003368A 2018-07-03 2020-12-23 Composicion y metodo para tratar el dolor CL2020003368A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2018100924A AU2018100924A4 (en) 2018-07-03 2018-07-03 Composition and method for treating pain

Publications (1)

Publication Number Publication Date
CL2020003368A1 true CL2020003368A1 (es) 2021-08-13

Family

ID=63079646

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020003368A CL2020003368A1 (es) 2018-07-03 2020-12-23 Composicion y metodo para tratar el dolor

Country Status (13)

Country Link
US (1) US20220218650A1 (es)
EP (1) EP3817733A4 (es)
KR (1) KR20210071939A (es)
AU (2) AU2018100924A4 (es)
BR (1) BR112020027080A2 (es)
CA (1) CA3104742A1 (es)
CL (1) CL2020003368A1 (es)
CO (1) CO2021001061A2 (es)
IL (1) IL279748A (es)
MX (1) MX2021000020A (es)
PE (1) PE20211650A1 (es)
SG (1) SG11202013239RA (es)
WO (1) WO2020006599A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190035791A (ko) 2016-08-03 2019-04-03 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
AU2018286647B2 (en) 2017-06-19 2024-03-28 Zelira Therapeutics Operations Pty Ltd Sleep disorder compositions and treatments thereof
EP3856172A4 (en) * 2018-09-28 2022-10-05 Visceral Therapeutics Inc. PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF GASTROINTESTINAL CONDITIONS
AU2020243439A1 (en) * 2019-03-21 2021-10-28 ZYUS Life Sciences US Ltd. Cannabinoid and application supported opioid tapering
US12220396B2 (en) 2019-05-03 2025-02-11 Zyus Life Sciences Inc. Formulation for pain management
US12178797B2 (en) 2019-05-03 2024-12-31 Zyus Life Sciences Inc. Formulation for pain management
KR102445087B1 (ko) * 2019-05-03 2022-09-20 자이우스 라이프 사이언시스 아이엔씨. 통증 관리용 제형
WO2020232530A1 (en) * 2019-05-22 2020-11-26 Canopy Growth Corporation Cannabinoid-comprising compositions for management of pain
US20230218566A1 (en) * 2020-06-12 2023-07-13 Zelira Therapeutics Operations Pty Ltd Composition and Method for Treating Chronic Pain
CA3091622A1 (en) 2020-08-28 2022-02-28 Teresa Ann Hanlon Pain relieving formulations containing cannabis and methods of making same
KR102269823B1 (ko) * 2021-01-18 2021-06-28 주식회사 네이처센스 대마 추출물을 포함하는 대사성 질환의 예방 및 치료용 조성물
EP4362936A4 (en) * 2021-07-01 2025-04-30 Ananda Scientififc, Inc. CANNABINOID PAIN TREATMENT METHODS
WO2023126934A1 (en) * 2021-12-29 2023-07-06 Canonic Ltd. Cannabis compositions for treating pain and inflammation related disorders
JP2025503278A (ja) 2022-01-28 2025-01-30 バータニカル ゲーエムベーハー 植物抽出物の製造方法
JP2025504971A (ja) 2022-01-31 2025-02-19 バータニカル ゲーエムベーハー デルタ－９－テトラヒドロカンナビノールとテルペンを含む組成物
US20260069613A1 (en) * 2022-08-23 2026-03-12 Tribu Hemp Llc Cannabinoid and terpene composition to be applied on an absorbent material.
AU2024315631A1 (en) 2023-08-01 2026-01-22 Vertanical GmbH Composition for use in treatment and/or prevention of chronic musculoskeletal pain including chronic low back pain, chronic non-specific low back pain, osteoarthritis or other chronic musculoskeletal pain conditions comprising delta-9-tetrahydrocannabinol and terpenes

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949582B1 (en) * 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
CA2895805A1 (en) * 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
WO2016044370A1 (en) * 2014-09-16 2016-03-24 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
CA3135893C (en) * 2014-10-21 2023-11-14 United Cannabis Corp. Cannabis extracts and methods of preparing and using same
WO2017054071A1 (en) * 2015-01-21 2017-04-06 Willinsky Michael Composition and methods to improve stability, dosing, pharmacodynamics and product shelf life of endocannabinoids, phytocannabinoids and synthetic cannabinoids delivered by nasal inhaler
CA2952335A1 (en) * 2015-12-19 2017-06-19 Delta 9 Gardening B.V. Therapeutic delivery formulations and systems comprising cannabinoids and terpenes
PT3429580T (pt) * 2016-03-16 2025-08-12 Buzzelet Development And Technologies Ltd Composição de canabinoides enriquecida em terpenos
CA3065167A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
EP3703672A4 (en) * 2017-10-30 2021-12-01 Endocanna Health, Inc. CANNABINOID FORMULATIONS

Also Published As

Publication number Publication date
AU2019297198A1 (en) 2021-01-28
CA3104742A1 (en) 2020-01-09
AU2018100924A4 (en) 2018-08-09
IL279748A (en) 2021-03-01
MX2021000020A (es) 2021-05-27
PE20211650A1 (es) 2021-08-24
BR112020027080A2 (pt) 2021-03-30
SG11202013239RA (en) 2021-01-28
AU2019297198B2 (en) 2022-12-08
KR20210071939A (ko) 2021-06-16
EP3817733A1 (en) 2021-05-12
WO2020006599A1 (en) 2020-01-09
US20220218650A1 (en) 2022-07-14
CO2021001061A2 (es) 2021-06-30
EP3817733A4 (en) 2022-05-04

Similar Documents

Publication Publication Date Title
CO2021001061A2 (es) Composición y método para tratar el dolor
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
MX2018011348A (es) Composiciones de extractos naturales y uso de los mismos para prevenir o tratar enfermedades.
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CO2017004974A2 (es) Extractos de cannabis y métodos de preparación.
PE20200726A1 (es) Composicion de cannabis
MX2017014195A (es) Hidrogenacion de aceite de cannabis.
MX2019015315A (es) Composiciones y tratamientos para el trastorno del sueño.
MX2021008702A (es) Uso de cannabinoides en el tratamiento de las comorbilidades asociadas a la epilepsia.
PE20230607A1 (es) Composicion de cannabis
PE20200676A1 (es) Composicion de cannabis
MX2017015083A (es) Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimeto xi-3,3-dimetilindan-1-ona.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2022003507A1 (es) Composición y método para tratar el dolor crónico
BR112016017612A2 (pt) Uso de um extrato de uma planta do gênero mentha da família lamiaceae
CL2020003374A1 (es) Composicion y metodo de cannabinoides para tratar el tept y/o la ansiedad
CL2020002646A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
NI201900004A (es) Composición vaginal comprendiendo una combinación de estrógeno y vitamina d.
CO2021012893A2 (es) Polímero superabsorbente y método para aumentar el contenido de azúcar en plantas
EA201991659A1 (ru) Композиция от кашля
MX2021008602A (es) Composicion para el tratamiento y/o prevencion de sintomas del tracto urinario inferior.
MX2022007720A (es) Extractos enriquecidos con compuestos polifenolicos y metodos relacionados.
BR112018001693A2 (pt) composição farmacêutica para prevenção de queda de cabelo ou promoção de crescimento de cabelo, método para prevenir a queda de cabelo e método para promover o crescimento do cabelo
CL2021001076A1 (es) Composición farmacéutica que comprende una combinación de 1,3-2,5% de tetrahidrocannabinol (thc) y 0,6-1,4% de cannabidiol (cbd); su proceso de elaboración; y su uso para el tratamiento del dolor crónico refractario.
AR116986A1 (es) Composición cosmética, método para la producción de aceite y/o manteca de astrocaryum vulgare, uso de la composición cosmética y método para la producción y/o protección contra la degradación del ácido hialurónico en la piel